In the current era of rapid medical development, China has made remarkable progress in the diagnosis and treatment of tumors, especially in the fields of precision medicine, immunotherapy, and multidisciplinary comprehensive treatment, where new research achievements and clinical practice breakthroughs have been constantly emerging. However, the complexity and diversity of tumors still pose many challenges for clinicians and researchers. After research, the continuing education activity "Progress in Multidisciplinary Precision Treatment of Malignant Tumors" jointly organized by Chengdu High-tech Medical Association and Chengdu BOE Hospital was successfully held at Chengdu BOE Hospital on July 6, 2025.

The opening ceremony of the conference was presided over by Professor Yu Xiaolin from Chengdu BOE Hospital. Vice President Wang Cunbang of Chengdu BOE Hospital and Professor Hou Mei from West China Hospital of Sichuan University attended the opening ceremony of the conference and delivered speeches.

The grand opening of the conference brought together renowned experts and scholars in the field, like a river of wisdom, jointly exploring new paths for tumor prevention and treatment in the era of precision medicine. Experts deeply analyzed typical cases of new treatment progress, and through wonderful lectures, demonstrated the innovative sparks sparked by the collision of ideas among different disciplines, opening up more possible paths for the diagnosis and treatment of complex cases.

This conference aims to build a high-level academic exchange platform, gathering renowned experts, scholars and clinical doctors in the field of oncology from both within and outside the province. Together, they will focus on the cutting-edge and hot issues in tumor diagnosis and treatment, and explore new diagnostic and therapeutic ideas and methods through in-depth thinking and communication. Only by integrating the sharp edge of precision medicine with the solid strength of multi-disciplinary collaboration can a new chapter of life be truly illuminated for cancer patients. When the precise technological brilliance and the benevolent hearts of medical practitioners shine upon each other, a clearer and more hopeful dawn is unfolding ahead in the field of tumor treatment.